Sanofi-Aventis has received approval to market Rimonabant as a prescription anti-obesity drug in the European Union, subject to some restrictions, however, in October 2008, the European Medicines Agency (EMEA) recommended this.
Acomplia no longer be available in UK. Sanofi-Aventis has received approval to market Rimonabant as a prescription anti-obesity drug in the European Union however, the European Medicines Agency (EMEA) recommended this. This was in October 2008. This was subject to some restrictions.